Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neuroepidemiology

Clinical differences between elderly and non-elderly chronic subdural hematoma patients

Provisionally accepted
Yongxiang  YangYongxiang YangDongbo  ZouDongbo ZouYuan  MaYuan MaKexia  FanKexia FanXiansong  ZhuXiansong ZhuLi  YunxingLi YunxingWanlin  LiangWanlin LiangJie  WangJie WangJingmin  ChengJingmin Cheng*Tao  YangTao Yang*
  • Department of Neurosurgery, Western Theater General Hospital, Chengdu, China

The final, formatted version of the article will be published soon.

Objective Chronic subdural hematoma (CSDH) is a common disease in elderly population, which can also be seen in young and middle-aged individuals. In order to understand the clinical features of this disease deeply, we conducted this retrospective study to clarify the clinical differences between elderly and non-elderly CSDH patients. Methods According to the inclusion and exclusion criteria, 268 elderly CSDH patients and 87 non-elderly CSDH patients were recruited from January 2015 to December 2024 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24h of hospital admission, as well as the treatment method and clinical outcome of elderly and non-elderly CSDH patients. Results Compared to non-elderly CSDH patients, female was more frequent, the traumatic events were less common, and the history of taking anticoagulants and antiplatelet drugs were more common in elderly CSDH patients (all P<0.05). Moreover, the hematoma was thicker and larger, the usage of atorvastatin was more common, the recurrence rate was higher, and the mean hospital stay was longer in elderly CSDH patients than in non-elderly CSDH patients (all P<0.05). Conclusion Elderly CSDH patients were less likely to have the traumatic events and more likely to have the history of taking anticoagulants/antiplatelet drugs, who were also owing the higher rate of using atorvastatin and hematoma recurrence, compared to non-elderly CSDH patients.

Keywords: chronic subdural hematoma, Clinical Characteristics, clinical outcome, Elderly, Non-elderly

Received: 08 Feb 2026; Accepted: 09 Feb 2026.

Copyright: © 2026 Yang, Zou, Ma, Fan, Zhu, Yunxing, Liang, Wang, Cheng and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jingmin Cheng
Tao Yang

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.